
Delhi HC Dismisses Novo Nordisk's Appeal To Block Dr Reddy's Key Ozempic Ingredient Exports
NDTV
Novo's patent is set to expire on March 20, 2026.
Novo's patent is set to expire on March 20, 2026. This development comes after Novo Nordisk was preparing to unveil its semaglutide based drug 'Extensior' in India.
More Related News













